Typically, patients with a deficiency might start with more frequent injections, often weekly, and then switch to monthly maintenance doses once levels stabilize
In adults with overweight or obesity and cardiovascular disease, but without diabetes, semaglutide reduced major adverse cardiovascular events at a mean of 40 months [32] [33]
Over time, this dietary reduction could contribute to anemia, particularly if individuals are not carefully planning their meals to include nutrient-dense options
& Coussens, L
Navigating Weight Loss and Acid Reflux: Can You Take Omeprazole with Tirzepatide
The result at week 68: Continued semaglutide 2.4 mg: lost an additional 7.9% of body weight (total loss from baseline: 17.4%) Switched to placebo: regained 6.9% of body weight (net loss from baseline: 5.0%) Thats a roughly 15-point difference in body weight between the two groups at the end of the trial, attributable entirely to whether the medication continued